Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Auro Laboratories Ltd

AUROLAB·BSE

₹253.70+1.44%Tue, 22 Sept '26 15:28

Industry:Pharmaceuticals Bulk Drugs

Indices:

Auro Laboratories Ltd

AUROLAB

BSE

₹253.70

+1.44%

|Tue, 22 Sept '26 15:28

SOICxStockScans Reports

Industry

Pharmaceuticals Bulk Drugs

Indices

View

Financials

Documents

Shareholdings

Corporate Actions

Segments

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Financials

Documents

Shareholdings

Corporate Actions

Segments

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Quick Ratios

Edit Ratios

Mkt Cap

Market Capitalization

₹158Cr

Close Price

₹253.70

Industry

Pharmaceuticals Bulk Drugs

Price To Earnings

33.74

Price To Sales

4.29

Revenue

₹37Cr

Rev Gr TTM

Revenue Growth TTM

125.67%

PAT Gr TTM

PAT Growth TTM

579.71%

Quarterly Results

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	13	18	12	6	3	3	7	3	9	9	10	9
Growth YoY Revenue Growth YoY%	6.8	15.1	-10.8	-43.8	-76.9	-83.0	-38.6	-51.6	185.2	207.9	32.8	216.6
Expenses ExpensesCr	10	14	10	4	2	3	7	3	6	5	7	5
Operating Profit Operating ProfitCr	3	4	2	1	1	0	1	0	2	4	3	3
OPM OPM%	22.6	22.7	19.9	23.1	23.2	14.4	11.1	0.7	26.7	43.2	33.8	37.6
Other Income Other IncomeCr	0	0	0	0	0	0	0	0	1	0	1	0
Interest Expense Interest ExpenseCr	0	0	0	0	0	0	0	0	1	2	1	1
Depreciation DepreciationCr	0	0	0	0	0	0	0	0	1	1	1	1
PBT PBTCr	3	4	3	1	0	0	0	0	2	2	1	1
Tax TaxCr	1	1	1	0	0	0	0	0	1	0	0	0
PAT PATCr	2	3	2	1	0	0	0	0	1	2	1	1
Growth YoY PAT Growth YoY%	838.1	637.8	30.3	5.6	-81.7	-98.2	-83.2	-114.7	100.0	3,800.0	148.7	1,054.5
NPM NPM%	14.7	15.2	19.2	13.1	11.6	1.6	5.3	-4.0	8.1	20.8	9.9	12.0
EPS EPS₹	3.2	4.4	3.7	1.2	0.6	0.1	0.6	-0.2	1.1	3.1	1.6	1.7

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	13	18	12	6	3	3	7	3	9	9	10	9
Growth YoY Revenue Growth YoY%	6.8	15.1	-10.8	-43.8	-76.9	-83.0	-38.6	-51.6	185.2	207.9	32.8	216.6
Expenses ExpensesCr	10	14	10	4	2	3	7	3	6	5	7	5
Operating Profit Operating ProfitCr	3	4	2	1	1	0	1	0	2	4	3	3
OPM OPM%	22.6	22.7	19.9	23.1	23.2	14.4	11.1	0.7	26.7	43.2	33.8	37.6
Other Income Other IncomeCr	0	0	0	0	0	0	0	0	1	0	1	0
Interest Expense Interest ExpenseCr	0	0	0	0	0	0	0	0	1	2	1	1
Depreciation DepreciationCr	0	0	0	0	0	0	0	0	1	1	1	1
PBT PBTCr	3	4	3	1	0	0	0	0	2	2	1	1
Tax TaxCr	1	1	1	0	0	0	0	0	1	0	0	0
PAT PATCr	2	3	2	1	0	0	0	0	1	2	1	1
Growth YoY PAT Growth YoY%	838.1	637.8	30.3	5.6	-81.7	-98.2	-83.2	-114.7	100.0	3,800.0	148.7	1,054.5
NPM NPM%	14.7	15.2	19.2	13.1	11.6	1.6	5.3	-4.0	8.1	20.8	9.9	12.0
EPS EPS₹	3.2	4.4	3.7	1.2	0.6	0.1	0.6	-0.2	1.1	3.1	1.6	1.7

Profit & Loss

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	28	35	41	47	44	54	51	53	54	19	31	37
Growth Revenue Growth%	-14.5	27.1	15.0	14.8	-6.5	23.9	-6.2	4.0	1.4	-64.3	60.7	125.7
Expenses ExpensesCr	25	31	35	40	38	43	46	49	43	16	21	24
Operating Profit Operating ProfitCr	3	4	6	7	6	11	5	4	11	3	10	13
OPM OPM%	9.7	12.2	15.3	14.6	14.3	20.7	9.1	8.3	19.9	16.4	32.5	35.4
Other Income Other IncomeCr	0	1	1	1	1	1	1	1	2	1	2	2
Interest Expense Interest ExpenseCr	2	1	1	1	1	0	1	1	1	1	4	5
Depreciation DepreciationCr	1	1	1	1	1	1	1	1	1	1	3	3
PBT PBTCr	1	3	5	6	6	11	4	3	10	2	5	6
Tax TaxCr	0	2	1	2	2	3	1	1	3	0	1	1
PAT PATCr	1	1	4	4	4	7	3	2	8	2	4	5
Growth PAT Growth%	9.7	-7.6	333.0	24.6	-7.8	77.1	-60.4	-14.2	219.1	-76.4	92.1	579.7
NPM NPM%	3.2	2.3	8.7	9.4	9.3	13.2	5.6	4.6	14.5	9.6	11.5	12.7
EPS EPS₹	1.4	1.3	5.7	7.1	6.5	11.5	4.6	3.9	12.5	3.0	5.7	7.5

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	28	35	41	47	44	54	51	53	54	19	31	37
Growth Revenue Growth%	-14.5	27.1	15.0	14.8	-6.5	23.9	-6.2	4.0	1.4	-64.3	60.7	125.7
Expenses ExpensesCr	25	31	35	40	38	43	46	49	43	16	21	24
Operating Profit Operating ProfitCr	3	4	6	7	6	11	5	4	11	3	10	13
OPM OPM%	9.7	12.2	15.3	14.6	14.3	20.7	9.1	8.3	19.9	16.4	32.5	35.4
Other Income Other IncomeCr	0	1	1	1	1	1	1	1	2	1	2	2
Interest Expense Interest ExpenseCr	2	1	1	1	1	0	1	1	1	1	4	5
Depreciation DepreciationCr	1	1	1	1	1	1	1	1	1	1	3	3
PBT PBTCr	1	3	5	6	6	11	4	3	10	2	5	6
Tax TaxCr	0	2	1	2	2	3	1	1	3	0	1	1
PAT PATCr	1	1	4	4	4	7	3	2	8	2	4	5
Growth PAT Growth%	9.7	-7.6	333.0	24.6	-7.8	77.1	-60.4	-14.2	219.1	-76.4	92.1	579.7
NPM NPM%	3.2	2.3	8.7	9.4	9.3	13.2	5.6	4.6	14.5	9.6	11.5	12.7
EPS EPS₹	1.4	1.3	5.7	7.1	6.5	11.5	4.6	3.9	12.5	3.0	5.7	7.5

Balance Sheet

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	6	6	6	6	6	6	6	6	6	6	6
Reserves ReservesCr	2	3	7	11	15	22	25	28	36	37	40
Current Liabilities Current LiabilitiesCr	10	6	7	6	6	9	20	18	24	22	29
Non Current Liabilities Non Current LiabilitiesCr	7	11	11	10	5	4	3	4	20	34	46
Total Liabilities Total LiabilitiesCr	26	27	30	33	32	42	55	56	86	99	121
Current Assets Current AssetsCr	12	14	16	19	18	28	38	36	31	21	31
Non Current Assets Non Current AssetsCr	13	13	14	15	14	14	17	20	55	78	90
Total Assets Total AssetsCr	26	27	30	33	32	42	55	56	86	99	121

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	6	6	6	6	6	6	6	6	6	6	6
Reserves ReservesCr	2	3	7	11	15	22	25	28	36	37	40
Current Liabilities Current LiabilitiesCr	10	6	7	6	6	9	20	18	24	22	29
Non Current Liabilities Non Current LiabilitiesCr	7	11	11	10	5	4	3	4	20	34	46
Total Liabilities Total LiabilitiesCr	26	27	30	33	32	42	55	56	86	99	121
Current Assets Current AssetsCr	12	14	16	19	18	28	38	36	31	21	31
Non Current Assets Non Current AssetsCr	13	13	14	15	14	14	17	20	55	78	90
Total Assets Total AssetsCr	26	27	30	33	32	42	55	56	86	99	121

Cash Flow

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	8	6	6	7	9	13	-7	3	19	5	2
Investing Cash Flow Investing Cash FlowCr	-2	-2	-3	-3	-2	-4	-5	-5	-39	-24	-15
Financing Cash Flow Financing Cash FlowCr	-5	-4	-2	-2	-6	0	10	-8	19	18	14
Net Cash Flow Net Cash FlowCr	0	0	1	2	2	9	-2	-10	-1	-1	1
Free Cash Flow Free Cash FlowCr	8	6	6	7	9	13	-7	3	19	5	-55
CFO To PAT CFO To PAT%	893.6	795.9	171.5	156.2	229.4	178.5	-231.7	134.4	241.4	273.0	59.8
CFO To EBITDA CFO To EBITDA%	291.8	150.0	97.1	100.4	148.3	114.0	-142.5	74.7	176.3	160.4	21.1

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	8	6	6	7	9	13	-7	3	19	5	2
Investing Cash Flow Investing Cash FlowCr	-2	-2	-3	-3	-2	-4	-5	-5	-39	-24	-15
Financing Cash Flow Financing Cash FlowCr	-5	-4	-2	-2	-6	0	10	-8	19	18	14
Net Cash Flow Net Cash FlowCr	0	0	1	2	2	9	-2	-10	-1	-1	1
Free Cash Flow Free Cash FlowCr	8	6	6	7	9	13	-7	3	19	5	-55
CFO To PAT CFO To PAT%	893.6	795.9	171.5	156.2	229.4	178.5	-231.7	134.4	241.4	273.0	59.8
CFO To EBITDA CFO To EBITDA%	291.8	150.0	97.1	100.4	148.3	114.0	-142.5	74.7	176.3	160.4	21.1

Ratios

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	13	26	54	37	20	51	63	34	100	144	165	158
Price To Earnings Price To Earnings	14.2	31.7	15.2	8.4	4.8	7.0	22.0	13.9	12.9	78.2	46.7	33.7
Price To Sales Price To Sales	0.5	0.7	1.3	0.8	0.5	0.9	1.2	0.6	1.9	7.5	5.4	4.3
Price To Book Price To Book	1.5	2.8	4.1	2.1	0.9	1.8	2.0	1.0	2.4	3.3	3.6	3.4
EV To EBITDA EV To EBITDA	9.1	6.9	9.7	6.0	2.7	3.5	13.8	8.7	11.7	60.1	22.7	16.7
Profitability Ratios Profitability Ratios
GPM GPM%	29.7	29.9	32.8	32.5	36.5	40.6	28.8	25.9	44.9	49.6	72.9	72.9
OPM OPM%	9.7	12.2	15.3	14.6	14.3	20.7	9.1	8.3	19.9	16.4	32.5	35.4
NPM NPM%	3.2	2.3	8.7	9.4	9.3	13.2	5.6	4.6	14.5	9.6	11.5	12.7
ROCE ROCE%	11.5	27.8	26.2	26.6	25.2	34.7	10.4	10.5	16.3	3.4	8.3	8.3
ROE ROE%	10.3	8.7	27.2	25.3	18.9	25.1	9.0	7.1	18.6	4.3	7.6	7.6
ROA ROA%	3.4	3.0	11.6	13.2	12.5	17.1	5.2	4.4	9.1	1.9	2.9	2.9
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	13	26	54	37	20	51	63	34	100	144	165	158
Price To Earnings Price To Earnings	14.2	31.7	15.2	8.4	4.8	7.0	22.0	13.9	12.9	78.2	46.7	33.7
Price To Sales Price To Sales	0.5	0.7	1.3	0.8	0.5	0.9	1.2	0.6	1.9	7.5	5.4	4.3
Price To Book Price To Book	1.5	2.8	4.1	2.1	0.9	1.8	2.0	1.0	2.4	3.3	3.6	3.4
EV To EBITDA EV To EBITDA	9.1	6.9	9.7	6.0	2.7	3.5	13.8	8.7	11.7	60.1	22.7	16.7
Profitability Ratios Profitability Ratios
GPM GPM%	29.7	29.9	32.8	32.5	36.5	40.6	28.8	25.9	44.9	49.6	72.9	72.9
OPM OPM%	9.7	12.2	15.3	14.6	14.3	20.7	9.1	8.3	19.9	16.4	32.5	35.4
NPM NPM%	3.2	2.3	8.7	9.4	9.3	13.2	5.6	4.6	14.5	9.6	11.5	12.7
ROCE ROCE%	11.5	27.8	26.2	26.6	25.2	34.7	10.4	10.5	16.3	3.4	8.3	8.3
ROE ROE%	10.3	8.7	27.2	25.3	18.9	25.1	9.0	7.1	18.6	4.3	7.6	7.6
ROA ROA%	3.4	3.0	11.6	13.2	12.5	17.1	5.2	4.4	9.1	1.9	2.9	2.9
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Documents — Auro Laboratories Ltd

Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/704i4eu4x02sfr1srpbk48ky.pdf
Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/v832kiu0vjghwss7aurgd0wf.pdf
Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/fs29fxmb8i365l73785dhh9i.pdf
Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ckmvbgouzrf8la3n6ar2uc3j.pdf
Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/40v715wfvkcuvebmav98sbo0.pdf
Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/94r4ucmms9z5wbfinzr60ygr.pdf
Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/qmhfqpyfwccd4gt8duvl3glh.pdf
Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/nnnc02ws8sh1dx4y0i9c1p8s.pdf
FY2026 Annual Report (PDF): https://www.stockscans.in/document/ethnrapglahcdecwyixqzyea.pdf
FY2025 Annual Report (PDF): https://www.stockscans.in/document/8gp55muo7t8ob3kg98m7qy4b.pdf
FY2024 Annual Report (PDF): https://www.stockscans.in/document/0lyi3fuw0nc9xwgp4deunac7.pdf
FY2023 Annual Report (PDF): https://www.stockscans.in/document/ome0dboux9nloaf1semf9f51.pdf
FY2022 Annual Report (PDF): https://www.stockscans.in/document/55533x0b6k6q367e88c1wygu.pdf
FY2021 Annual Report (PDF): https://www.stockscans.in/document/sz9vw5v1l9i0h0gk62w7czea.pdf
FY2020 Annual Report (PDF): https://www.stockscans.in/document/d81fex3vieszw5bnx6phtltu.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in

349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies